Can SARS-CoV-2 be transmitted via faeces?

被引:16
作者
Moura, Ines B. [1 ]
Buckley, Anthony M. [1 ]
Wilcox, Mark H. [1 ,2 ]
机构
[1] Univ Leeds, Leeds Inst Med Res, Fac Med & Hlth, Healthcare Associated Infect Grp, Leeds, W Yorkshire, England
[2] Leeds Teaching Hosp NHS Trust, Old Med Sch, Leeds Gen Infirm, Microbiol, Leeds, W Yorkshire, England
关键词
COVID-19; faecal transmission; gastrointestinal symptoms; gut microbiota; SARS-CoV-2; INFECTION; COVID-19;
D O I
10.1097/MOG.0000000000000794
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review COVID-19 patients can present gastrointestinal symptoms, being diarrhoea one of the most frequent, suggesting intestinal health can be impacted by COVID-19. Here, we will discuss whether there is a correlation between the presence of SARS-CoV-2 RNA in faeces and diarrhoea, the relevance of gastrointestinal symptoms in disease diagnosis and transmission, and how COVID-19 can impact the gut microbial balance. Recent findings SARS-CoV-2 RNA has been reported in faeces or rectal swabs of COVID-19 patients with and without diarrhoea, suggesting faecal shedding can occur independently of gastrointestinal symptoms. However, the presence of the virus in the intestine can persist beyond its presence in the respiratory tract, with some reports suggesting that SARS-CoV-2 in the faeces can be infectious. COVID-19 can impact the gut microbiota causing an enhancement of biosynthesis pathways that favour the expansion of bacterial pathogens in the inflamed gut, and causing a decline in commensals involved in the human immune response. Gastrointestinal symptoms may be the first indication of COVID-19. SARS-CoV-2 in faeces can potentiate routes of disease transmission, particularly as the high viral loads reported in patients with severe illness suggest virus replication in the intestine may be possible.
引用
收藏
页码:26 / 29
页数:4
相关论文
共 50 条
  • [31] The panzootic potential of SARS-CoV-2
    Mabry, Makenzie E.
    Fanelli, Angela
    Mavian, Carla
    Lorusso, Alessio
    Manes, Costanza
    Soltis, Pamela S.
    Capua, Ilaria
    BIOSCIENCE, 2023, 73 (11) : 814 - 829
  • [32] Antigenic Cartography of SARS-CoV-2
    Astakhova, Ekaterina A.
    Morozov, Alexey A.
    Vavilova, Julia D.
    Filatov, Alexander V.
    BIOCHEMISTRY-MOSCOW, 2024, 89 (05) : 862 - 871
  • [33] The Emergence and Evolution of SARS-CoV-2
    Holmes, Edward C.
    ANNUAL REVIEW OF VIROLOGY, 2024, 11 : 21 - 42
  • [34] SARS-CoV-2 and the cardiovascular system
    Hafiane, Anouar
    CLINICA CHIMICA ACTA, 2020, 510 : 311 - 316
  • [35] The evolving epidemiology of SARS-CoV-2
    Bennett, Catherine M.
    Vally, Hassan
    MICROBIOLOGY AUSTRALIA, 2024, 45 (01) : 4 - 7
  • [36] Movement Disorders and SARS-CoV-2
    Fung, Wilson K. W.
    Fasano, Alfonso
    Fearon, Conor
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2022, : S9 - S17
  • [37] Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?-A Comprehensive Review
    Majeed, Muhammed
    Nagabhushanam, Kalyanam
    Prakasan, Priji
    Mundkur, Lakshmi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [38] Imported and locally transmitted mild SARS-CoV-2 pneumonia cases in Japan
    Tochitani, Kentaro
    Iwamoto, Nobuki
    Motobayashi, Hirofumi
    Yamamoto, Shungo
    Shimizu, Tsunehiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (08) : 854 - 857
  • [39] Can Robots Improve Testing Capacity for SARS-CoV-2?
    Cresswell, Kathrin
    Ramalingam, Sandeep
    Sheikh, Aziz
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (08)
  • [40] Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
    Moran, Angelica
    Beavis, Kathleen G.
    Matushek, Scott M.
    Ciaglia, Carol
    Francois, Nina
    Tesic, Vera
    Love, Nedra
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)